PT  - JOURNAL ARTICLE
AU  - Perera, Sanjeewa Nishantha
AU  - Ganegoda, Naleen C
AU  - Siriwardhana, Dhammika Deepani
AU  - Weerasinghe, Manuj C
TI  - Mathematical Model to Study Early COVID-19 Transmission Dynamics in Sri Lanka
AID  - 10.1101/2020.04.27.20082537
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.27.20082537
4099  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20082537.short
4100  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20082537.full
AB  - Background World Health Organization declared COVID-19 as a pandemic on 11th March. Sri Lanka is currently experiencing a cluster epidemic with a specific group of overseas returnees and their contacts. The objective of this study was to develop a mathematical model to predict the epidemic in Sri Lanka incorporating measures taken for social distancing and prevention of social gatherings.Methods A hybrid model incorporating both exponential and polynomial features was developed and parameters were estimated. The developed model was validated using the datasets of three reference countries. Finally, the model was applied to the Sri Lankan data to simulate the epidemic behaviour. Additional features were incorporated to the model to examine the effects of current control measures.Findings Sri Lanka will have a peak of 177 COVID-19 active cases at the end of second incubation period from the index case of our projection, if the same trend continues. At 10% risk, we project a peak of 263 COVID-19 active cases at the end of third incubation period, and a peak of 353 at the end of fourth incubation period. Should the risk level reach 20%, the peak will be above 1000 active cases after 90 days. Simulations incorporating control measures predict that, deviation from the control measures currently in place could trigger exponential behaviour of the epidemic.Interpretation The hybrid model combining exponential and polynomial functions showed promising results to predict COVID-19 epidemic. Projections indicate that any early relaxation of control measures is not advisable. This methodological approach can be replicated in other settings at the initial stages of the epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe did not receive any funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from the authors upon a reasonable request.